Pd-catalyzed direct C-H arylation overcomes the need
for expensive organometallic reagents.10 The reaction has
been demonstrated on a wide range of heterarenes by using
cheap aryl halides.11 While many publications appear in the
literature about direct C-H arylation of thiazoles,10,12 to the
best of our knowledge, there have been no reported examples
of Pd-catalyzed direct arylation of isothiazoles.
inorganic bases such as KF, CsF, K2CO3, Cs2CO3,
and Na2CO3 and organic bases such as pyridine and i-Pr2-
NEt failed to work. In light of this, we investigated the use
ofsilver(I) salts, which are effectiveadditivesinbothoxida-
tive18 and nonoxidative arylations.12d,19
The addition of AgNO3 assisted the Pd-catalyzed
arylation of allyltrimethylsilanes,20 vinylsilanes,21 while
Ag2O promoted the Pd-catalyzed cross-coupling reactions
of silanols, silanediols, and silanetriols22 as well the reac-
tion between aryl and alkenyl halides with terminal
alkynes.23 Silver(I) fluoride (AgF) served as both an acti-
vator of the electrophilic substitution reaction and as
the oxidant of Pd(0),24 and in combination with Cu(II)
salts aided the arylation of acetanilides.19e Furthermore,
AgF was used as base for the arylation of thiophenes and
thiazoles.12b,25
During ongoing studies on the versatile 3,5-dibromo-
and3,5-dichloroisothiazole-4-carbonitriles,13 wedeveloped
chromatography free gram scale conditions for the regios-
pecific C5 hydrodehalogenations that gave 3-bromo- and
3-chloroisothiazole-4-carbonitriles 1a and 1b, respectively.
Combining the 3-haloisothiazole-4-carbonitriles with Pd-
catalyzed C-H direct arylations can be a new route to
5-arylisothiazole-4-carbonitriles that are important due to
their cytotoxicity14 and antiviral activity.14,15 To date these
compounds have been prepared by either treating arylyli-
denemalononitriles with S2Cl26b,14,16 or by arylating halo-
isothiazolesusing Suzuki, Stille, or Negishi reactions.6b,7b,17
However, the former has limitations due to harsh reaction
conditions that often lead to chlorination of electron-rich
aryls and the latter requires often expensive reagents. Below
we demonstrate for the first time the efficient silver-mediated
Pd-catalyzed direct C5 arylation of 3-bromoisothiazole-4-
carbonitrile (1a) using readily available iodoarenes.
In light of the above, we treated 3-bromoisothiazole-
4-carbonitrile (1a) with PhI (1.2 equiv), AgF (2 equiv),
Pd(dppf)Cl2 DCM (20 mol %), and Ph3P as ligand
3
(10 mol %) in MeCN at ca. 82 °C for 2 h and obtained
the 5-phenylisothiazole (2a) in 73% yield. Substituting PhI
for PhBr or PhCl gave only traces of product after 2 h. The
conditions were subsequently optimized with respect to
catalyst, ligand, and base/oxidant (Table 1). Of the cata-
lysts screened, Pd(Ph3P)2Cl2 gave the highest yield (88%)
in the shortest time (20 min) and was chosen for further
optimization. In contrast Pd2(dba)3 gave a complex reac-
tion mixture, while Pd(OAc)2 and (MeCN)2PdCl2 gave the
desired product in only moderate yields and required
longer reaction times.
Initially, 3-bromoisothiazole-4-carbonitrile (1a) was
treated with either chloro-, bromo-, or iodobenzene (PhI) in
the presence of a Pd catalyst Pd(dppf)Cl2 DCM (20 mol %)
3
and base in MeCN at ca. 82 °C. Surprisingly, the use of
On holding constant the catalyst, Pd(Ph3P)2Cl2 (20
mol %), both the reaction time and product yield were
affected by varying the equivalents of PhI; the highest
yields (88and 84%) were achieved with 1.2 and 1.5 equiv of
PhI over a 20 and 10 min period, respectively. In the
absence of additional ligand, the product can still be
formed in good yield by increasing the PhI equivalents.
Switching the ligand to dppf (10 mol %) led to a longer
reaction (7 h) and a 67% product yield, while the use of
JohnPhos (10 mol %) gave only traces of product after 4 h.
The catalyst loading was then investigated to find the
minimum needed for the reaction to succeed. Reducing
thecatalystloadingto10mol % with1.2 equivofPhIled to
longer reaction times (7 h) and moderate product yields
(60%) and gavetraces of 3,30-dibromo-5,50-biisothiazole-
4,40-dicarbonitrile (3a) presumably owing to a competing
oxidative C5 dimerization. The formation of the latter can
be suppressed by increasing the PhI to 1.5 or 2 equiv, which
(11) (a) Ritleng, V.; Sirlin, C.; Pfeffer, M. Chem. Rev. 2002, 102, 1731.
(b) Alberico, D.; Scott, M. E.; Lautens, M. Chem. Rev. 2007, 107, 174.
(c) Campeau, L.-C.; Stuart, D. R.; Fagnou, K. Aldrichim. Acta 2007, 40,
35. (d) Roger, J.; Doucet, H. Org. Biomol. Chem. 2008, 6, 169. (e)
Gottumukkala, A. L.; Derridj, F.; Djebbar, S.; Doucet, H. Tetrahedron
Lett. 2008, 49, 2926. (f) Ackermann, L.; Vincente, R.; Born, R. Adv.
Synth. Catal. 2008, 350, 741. (g) Gottumukkala, A. L.; Doucet, H. Adv.
Synth. Catal. 2008, 350, 2183.
(12) (a) Yokooji, A.; Okazawa, T.; Satoh, T.; Miura, M.; Nomura,
M. Tetrahedron 2003, 59, 5685. (b) Masui, K.; Mori, A.; Okano, K.;
Takamura, K.; Kinoshita, M.; Ikeda, T. Org. Lett. 2004, 6, 2011. (c)
Kobayashi, K.; Ahmed, M. S. M.; Mori, A. Tetrahedron 2006, 62, 9548.
(d) Turner, G. L.; Morris, J. A.; Greaney, M. F. Angew. Chem., Int. Ed.
2007, 46, 7996. (e) Gottumukkala, A. L.; Doucet, H. Eur. J. Inorg. Chem.
2007, 3629. (f) Roger, J.; Doucet, H. Org. Biomol. Chem. 2008, 6, 169. (g)
ꢁ
Liegault, B.; Lapointe, D.; Caron, L.; Vlassova, A.; Fagnou, K. J. Org.
Chem. 2009, 74, 1826.
(13) Hatchard, W. R. J. Org. Chem. 1964, 29, 660.
ꢂ
(14) Cutri, C. C. C.; Garozzo, A.; Siracusa, M. A.; Sarva, M. C.;
ꢂ
Tempera, G.; Geremia, E.; Pinizzotto, M. R.; Guerrera, F. Bioorg. Med.
Chem. 1998, 6, 2271.
ꢂ
(15) Cutri, C. C. C.; Garozzo, A.; Siracusa, M. A.; Sarva, M. C.;
ꢂ
Castro, A.; Geremia, E.; Pinizzotto, M. R.; Guerrera, F. Bioorg. Med.
Chem. 1999, 7, 225.
(16) Nakagawa, S.; Okumura, J.; Sakai, F.; Hoshi, H.; Naito, T.
Tetrahedron Lett. 1970, 11, 3719.
(17) Ioannidou, H. A.; Koutentis, P. A. Tetrahedron 2009, 65, 7023.
(18) (a) Hull, K. L.; Sanford, M. S. J. Am. Chem. Soc. 2007, 129,
11904. (b) Cho, S. H.; Hwang, S. J.; Chang, S. J. Am. Chem. Soc. 2008,
130, 9254. (c) Wang, C.; Piel, I.; Glorius, F. J. Am. Chem. Soc. 2009, 131,
4194.
(19) (a) Shabashov, D.; Daugulis, O. Org. Lett. 2005, 7, 3657. (b)
Daugulis, O.; Zaitsev, V. G. Angew. Chem., Int. Ed. 2005, 44, 4046. (c)
Campeau, L.-C.; Parisien, M.; Jean, A.; Fagnou, K. J. Am. Chem. Soc.
2006, 128, 581. (d) Shabashov, D.; Daugulis, O. Org. Lett. 2006, 8, 4947.
(e) Lazareva, A.; Daugulis, O. Org. Lett. 2006, 8, 5211. (f) Yang, S.; Li,
B.; Wan, X.; Shi, Z. J. Am. Chem. Soc. 2007, 129, 6066. (g) Voutchkova,
A.; Coplin, A.; Leadbeater, N. E.; Crabtree, R. H. Chem. Commun.
2008, 6312. (h) Join, B.; Yamamoto, T.; Itami, K. Angew. Chem., Int. Ed.
2009, 48, 3644.
(20) Karabelas, K.; Westerlund, C.; Hallberg, A. J. Org. Chem. 1985,
50, 3896.
(21) Karabelas, K.; Hallberg, A. J. Org. Chem. 1986, 51, 5286.
(22) Hirabayashi, K.; Mori, A.; Kawashima, J.; Suguro, M.; Nishihara,
Y.; Hiyama, T. J. Org. Chem. 2000, 65, 5342.
(23) Mori, A.; Kawashima, J.; Shimada, T.; Suguro, M.; Hirabayashi,
K.; Nishihara, Y. Org. Lett. 2000, 2, 2935.
(24) Mori, A.; Sugie, A. Bull. Chem. Soc. Jpn. 2008, 181, 548.
(25) (a) Masui, K.; Ikegami, H.; Mori, A. J. Am. Chem. Soc. 2004,
126, 5074. (b) Kobayashi, K.; Sugie, A.; Takahashi, M.; Masui, K.;
Mori, A. Org. Lett. 2005, 7, 5083. (c) Masuda, N.; Tanba, S.; Sugie, A.;
Monguchi, D.; Koumura, N.; Hara, K.; Mori, A. Org. Lett. 2009, 11,
2297.
Org. Lett., Vol. 13, No. 6, 2011
1511